Tuesday, November 24, 2009, 3:33am EST - Canadian Markets open in 5 hours and 57 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Repligen Corp. (RGEN)

On Nov 23: 4.80 USD   0.00 (0.00%)  
MORE ON RGEN
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Mon, Nov 23, 2009
"Black Friday" deals may not signal retail comeback
Reuters (Mon 2:54pm)
Wed, Nov 11, 2009
REPLIGEN CORP Financials
EDGAR Online Financials (Wed, Nov 11)
Tue, Nov 10, 2009
UPDATE - Regeneron, Sanofi, expand drug partnership
at Reuters (Tue, Nov 10)
Sun, Nov 8, 2009
New Star Analyst Rankings for Repligen Corporation
StarMine (Sun, Nov 8)
Thu, Nov 5, 2009
Repligen Corp. F2Q09 (Qtr. End 09/30/09) Earnings Call Transcript
at Seeking Alpha (Thu, Nov 5)
Repligen Q2 Fiscal Year 2010 Earnings Call scheduled for 10:00 am ET today
CCBN (Thu, Nov 5)
REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 5)
Repligen Q2 Fiscal Year 2010 Earnings Release - Before Market Open
CCBN (Thu, Nov 5)
Repligen Reports Second Quarter Fiscal Year 2010 Financial Results
PRNewswire (Thu, Nov 5)
Tue, Nov 3, 2009
Repligen to Present at the Merriman Curhan Ford 6th Annual Investor Summit Tuesday, November 10th, 1:40 p.m. EST
PRNewswire (Tue, Nov 3)
Thu, Oct 29, 2009
Repligen Announces Conference Call of Second Quarter Fiscal Year 2010 Results Thursday, November 5th, 10:00 a.m. EST
PRNewswire (Thu, Oct 29)
Fri, Oct 23, 2009
Repligen Licenses Potential Treatment for Spinal Muscular Atrophy Call scheduled for 8:30 am ET today
CCBN (Fri, Oct 23)
Thu, Oct 22, 2009
Repligen Licenses Potential Treatment for Spinal Muscular Atrophy Conference Call Scheduled for Friday, October 23 at 8:30 a.m. EDT
PRNewswire (Thu, Oct 22)
Mon, Oct 19, 2009
Repligen Announces Completion of Patient Treatment in Phase 3 Clinical Trial of RG1068 in MRI Imaging of the Pancreas
PRNewswire (Mon, Oct 19)
Fri, Sep 25, 2009
Repligen Announces Identification of Drug Target for Friedreich's Ataxia Study Published in the September 25, 2009 issue of Chemistry & Biology
PRNewswire (Fri, Sep 25)
Wed, Sep 2, 2009
Repligen to Present at the Rodman & Renshaw 11th Annual Healthcare Conference Wednesday, September 9th, 2:25 p.m. EDT
PRNewswire (Wed, Sep 2)
Tue, Aug 25, 2009
REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Tue, Aug 25)
Wed, Aug 12, 2009
7 Highly Rated Stocks on Sale
at Motley Fool (Wed, Aug 12)
Thu, Aug 6, 2009
Repligen Q1 Fiscal Year 2010 Earnings Call scheduled for 10:00 am ET today
CCBN (Thu, Aug 6)
REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Aug 6)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices